好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson’s Disease: Systematic Review
Movement Disorders
P2 - Poster Session 2 (11:45 AM-12:45 PM)
3-011
This systematic review aims to consolidate existing evidence on the influence of preoperative MCI on postoperative DBS outcomes in patients with PD. By analyzing the methodological constraints of existing studies, this analysis aims to inform future research on the safety and efficacy of DBS surgery for patients with PD-MCI.
Despite the high estimated prevalence of mild cognitive impairment (MCI) among patients with Parkinson’s disease (PD), no published guidelines exist for determining post-operative risk after deep brain stimulation (DBS) among PD-MCI patients. While the benefits of DBS for the treatment of motor symptoms in advanced PD are well-established, few studies examine how preoperative MCI affects DBS outcomes.
A PRISMA-compliant systematic review across four databases was conducted for studies establishing preoperative MCI using at least one standardized measure and reporting post operative outcomes in PD-MCI patients. Data regarding mean disease duration, DBS target, follow up time points, MCI measures and clinical outcomes including QOL measures were extracted.

Of 330 records, 8 articles met inclusion criteria, spanning 580 total patients undergoing PD-DBS with pre-operative MCI. Of the 4 studies reporting a difference in PD-DBS outcomes in MCI patients, the differing outcomes in the MCI group involved cognitive domains and the rate of progression to dementia. None of the studies included a matched control of non-operated patients, although 7 included a PD-NC cohort. Three (37.5%) studies included at least one QOL measure.


The precise role of preoperative MCI on post-DBS outcomes remains speculative given the paucity of existing literature. Definitions of MCI are variable between studies, further complicating methodological comparisons. Furthermore, the clinical relevance of outcomes beyond standardized scales, such as QOL outcomes and caregiver burden, are less definitive. Ultimately, understanding the role of preoperative baseline characteristics, such as MCI, in surgical outcomes among PD DBS candidates could strengthen patient selection and counseling. 


Authors/Disclosures
Pooja Dhupati
PRESENTER
Ms. Dhupati has nothing to disclose.
Sunny Vansdadia Mr. Vansdadia has nothing to disclose.
Priya Ramaiah Ms. Ramaiah has nothing to disclose.
Cherry J. Barragan Mrs. Barragan has nothing to disclose.
Eujung G. Park Miss Park has nothing to disclose.
Robert Bina (Banner University Medical Center - Phoenix) No disclosure on file
Sara S. Dhanani, MD (Banner Sun Health Research Institute) Dr. Dhanani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.